Expert Opinion on Drug Delivery

Papers
(The H4-Index of Expert Opinion on Drug Delivery is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Metallic nanoparticles as drug delivery system for the treatment of cancer95
Wound dressings as growth factor delivery platforms for chronic wound healing57
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance50
Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung50
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation48
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection46
Clay nanoparticles as pharmaceutical carriers in drug delivery systems45
Microneedles for drug delivery: recent advances in materials and geometry for preclinical and clinical studies44
An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery42
Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors42
Manipulative magnetic nanomedicine: the future of COVID-19 pandemic/endemic therapy41
Advancing of titanium medical implants by surface engineering: recent progress and challenges40
Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies39
Extruded filaments derived 3D printed medicated skin patch to mitigate destructive pulmonary tuberculosis: design to delivery39
Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy37
Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications36
Orally administered self-emulsifying drug delivery system in disease management: advancement and patents36
Current trends in PLGA based long-acting injectable products: The industry perspective32
The sustainability of emerging technologies for use in pharmaceutical manufacturing32
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances32
Novel formulations of metal-organic frameworks for controlled drug delivery31
Biphasic drug release from electrospun structures31
Mesenchymal stem/stromal cells as next-generation drug delivery vehicles for cancer therapeutics30
An update on cell-penetrating peptides with intracellular organelle targeting27
Progress of delivery methods for CRISPR-Cas927
Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes26
0.10972189903259